JoaoProla NettoMD

PubMed

• 3 citations
  Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumors.
  Kutluay Uluc, Prakash Ambady, Matthew K McIntyre, John Philip Tabb, Caleb S Nerison, Amy Huddleston, Jesse J Liu, Aclan Dogan, Ryan A Priest, Rongwei Fu, Joao Prola Ne...> ;Neuro-Oncology Advances. 2022 Jun 25
• 6 citations
  Long-Term Outcomes of Intra-Arterial Chemotherapy for Progressive or Unresectable Pilocytic Astrocytomas: Case Studies
  Kutluay Uluc, Dominic A. Siler, Ricardo Lopez, Csanad Varallyay, Joao Prola Netto, Jenny Firkins, Cindy Lacy, Amy Huddleston, Prakash Ambady, Edward A. Neuwelt> ;Neurosurgery. 2021 Mar 15
• 6 citations
  Cystic appearance on magnetic resonance imaging in bihormonal growth hormone and prolactin tumors in acromegaly.
  Elena V. Varlamov, Matthew D. Wood, Joao Prola Netto, Jaclyn Thiessen, Jung Kim, Dawn Shao Ting Lim, Christine G. Yedinak, Justin S. Cetas, Maria Fleseriu> ;Pituitary. 2020 Dec 1
• 7 citations
  Quantitative comparison of delayed ferumoxytol T1 enhancement with immediate gadoteridol enhancement in high grade gliomas.
  Andrea Horváth, Csanad Varallyay, Daniel Schwartz, Gerda B. Toth, Joao Prola Netto, Ramon F. Barajas, Péter Várallyay, Laszlo Szidonya, Jenny Firkins, Emily Youngers, ...> ;Magnetic Resonance in Medicine. 2018 Jul 1
• 27 citations
  Neurovascular Unit: Basic and Clinical Imaging with Emphasis on Advantages of Ferumoxytol.
  Joao Prola Netto, Jeffrey J. Iliff, Danica Stanimirovic, Kenneth A. Krohn, Bronwyn E. Hamilton, Csanad Varallyay, Seymur Gahramanov, Heike E. Daldrup-Link, Christopher...> ;Neurosurgery. 2018 Jun 1
• 31 citations
  What Does the Boxed Warning Tell Us? Safe Practice of Using Ferumoxytol as an MRI Contrast Agent
  Csanad Varallyay, Gerda B. Toth, Rochelle Fu, Joao Prola Netto, Jenny Firkins, Prakash Ambady, Edward A. Neuwelt> ;AJNR. American Journal of Neuroradiology. 2017 Jul 1
• 185 citations
  Current and potential imaging applications of ferumoxytol for magnetic resonance imaging
  Gerda B. Toth, Csanad Varallyay, Andrea Horváth, Mustafa R. Bashir, Peter L. Choyke, Heike E. Daldrup-Link, Edit Dósa, J.P. Finn, Seymur Gahramanov, Mukesh G. Harising...> ;Kidney International. 2017 Jul 1
• 22 citations
  Patterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult C...
  Prakash Ambady, Rongwei Fu, Joao Prola Netto, Jenny Firkins, Nancy D. Doolittle, Edward A. Neuwelt, Cymon Kersch> ;Fluids and Barriers of the CNS. 2017 Jun 2
• 2 citations
  Misleading early blood volume changes obtained using ferumoxytol-based magnetic resonance imaging perfusion in high grade glial neoplasms treated with bevacizumab
  Joao Prola Netto, Daniel Schwartz, Csanad Varallyay, Rongwei Fu, Bronwyn E. Hamilton, Edward A. Neuwelt> ;Fluids and Barriers of the CNS. 2016 Dec 20
• 14 citations
  Intra-arterial administration improves temozolomide delivery and efficacy in a model of intracerebral metastasis, but has unexpected brain toxicity
  Leslie L. Muldoon, Michael A. Pagel, Joao Prola Netto, Edward A. Neuwelt> ;Journal of Neuro-Oncology. 2016 Feb 1
• 30 citations
  Diagnosis of pseudoprogression using MRI perfusion in patients with glioblastoma multiforme may predict improved survival
  Seymur Gahramanov, Csanad Varallyay, Rose Marie Tyson, Cynthia Lacy, Rongwei Fu, Joao Prola Netto, Morad Nasseri, Tricia White, Randy Woltjer, Sakir H. Gultekin, Edwar...> ;CNS Oncology. 2014 Dec 2
• 73 citations
  Evaluation of pseudoprogression in patients with glioblastoma multiforme using dynamic magnetic resonance imaging with ferumoxytol calls RANO criteria into question
  Morad Nasseri, Seymur Gahramanov, Joao Prola Netto, Rongwei Fu, Leslie L. Muldoon, Csanad Varallyay, Bronwyn E. Hamilton, Edward A. Neuwelt> ;Neuro-Oncology. 2014 Aug 1
• Join now to see all